Regulatory mechanisms of macrophage programming during dead cell clearance
Regulatory mechanisms of macrophage programming during dead cell clearance
批准号:
496418714
负责人:
Dr. Maria Tanzer, Ph.D.
金额:
$0.0万
依托单位国家:
德国
项目类别:
Independent Junior Research Groups
财政年份:
2022
资助国家:
德国
项目状态:
已结题
起止时间:
2021-12-31 至 2022-12-31
中文摘要
炎症性疾病通常伴随着增加的细胞死亡,这加剧了炎症。必须去除死细胞以解决炎症。因此,身体已经开发了一个过程称为红细胞增多症。有了这个,巨噬细胞被编程为识别和吞噬凋亡细胞。有效去除死细胞对于伤口愈合至关重要,并且是维持体内平衡的先决条件。红细胞增多症的缺陷会导致自身免疫性疾病,如类风湿性关节炎或红斑狼疮。这一过程在各种疾病环境中的调节是期望的,但需要深刻的知识。由于其复杂性,使用常规细胞生物学技术对红细胞增多症进行调查面临困难。首先,巨噬细胞在吞噬死细胞时必须处理大量过量的脂质、蛋白质和代谢物。其次,他们开发了在遇到高度炎症分子如核酸时避免炎症反应的策略。此外,吞噬巨噬细胞上调抗炎细胞因子,并在吞噬死细胞后发生显著的形态学变化。这些过程的基本机制在很大程度上仍然是未知的。因此,我们将应用最先进的蛋白质组学和遗传学方法,以获得前所未有的观点,进入驱动巨噬细胞和巨噬细胞重编程的关键事件。我们将a)动态磷酸化和泛素化的蛋白质,并使用遗传筛选确定功能相关的蛋白质,B)研究经历细胞器易位的蛋白质,以及c)鉴定在胞浆细胞增多期间释放的蛋白质,并检查它们在炎症中的功能。我们的研究结果将为巨噬细胞的适应性提供见解,并提供控制这一复杂过程及其对炎症的影响的方法。
英文摘要
Inflammatory diseases are typically accompanied by increased cell death, which exacerbates inflammation. Dead cells have to be removed to resolve inflammation. Therefore, the body has developed a process termed efferocytosis. With this, macrophages are programmed to recognise and phagocytose apoptotic cells. The efficient removal of dead cells is essential for wound healing and presents a prerequisite to maintain homeostasis. Defects in efferocytosis can lead to auto-immune diseases like rheumatoid arthritis or lupus erythematosus. Regulations of this process in various disease settings are desired, but require profound knowledge. Investigations of efferocytosis using conventional cell biology techniques face difficulties due to its complexity. Firstly, macrophages have to deal with a vast excess of lipids, proteins and metabolites when engulfing dead cells. Secondly, they developed strategies to avoid an inflammatory response when encountering highly inflammatory molecules like nucleic acids. Additionally, efferocytosing macrophages upregulate anti-inflammatory cytokines and undergo significant morphological changes upon engulfment of dead cells. The underlying mechanisms for these processes are still largely unknown. Therefore, we will apply cutting edge proteomic- and genetic approaches to obtain an unprecedented view into critical events that drive efferocytosis and macrophage reprogramming. We will a) characterise dynamically phosphorylated and ubiquitylated proteins and determine functional relevant proteins using genetic screens, b) investigate proteins that undergo organellar translocation and c) identify proteins, which are released during efferocytosis and examine their function in inflammation. Our results will provide insights into the adaptation of macrophages and offer handles to regulate this intricate process and its effect on inflammation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
Exploring the Intrinsic Mechanisms of CEO Turnover and Market
-
批准号:--
-
项目类别:外国学者研究基金
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI Z
-
依托单位:
Exploring the Intrinsic Mechanisms of CEO Turnover and Market Reaction: An Explanation Based on Information Asymmetry
-
批准号:W2433169
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:HAOFEI ZHANG
-
依托单位:
Erk1/2/CREB/BDNF通路在CSF1R相关性白质脑病致病机制中的作用研究
-
批准号:82371255
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:曹立
-
依托单位:
Foxc2介导Syap1/Akt信号通路调控破骨/成骨细胞分化促进颞下颌关节骨关节炎的机制研究
-
批准号:82370979
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张善勇
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
Idh3a作为线粒体代谢—表观遗传检查点调控产热脂肪功能的机制研究
-
批准号:82370851
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:包玉倩
-
依托单位:
小脑浦肯野细胞突触异常在特发性震颤中的作用机制及靶向干预研究
-
批准号:82371248
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:吴逸雯
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
声致离子电流促进小胶质细胞M2极化阻断再生神经瘢痕退变免疫机制
-
批准号:82371973
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:孙迪
-
依托单位:
用于小尺寸管道高分辨成像荧光聚合物点的构建、成像机制及应用研究
-
批准号:82372015
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:熊丽琴
-
依托单位: